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ABSTRACT 17 
Objective – To study the applicability of anatomical M-mode (AMM) for assessment of left 18 
ventricular (LV) size and function in horses, evaluate agreement with conventional M-mode 19 
(CMM), determine reliability, and establish reference intervals for AMM measurements. 20 
Animals – 98 horses; 13.1 ± 5.6 years; 538 ± 78 kg.  21 
Methods – Two-dimensional and M-mode recordings were analyzed retrospectively. 22 
Standard LV dimensions and indices of LV function, including time intervals, were measured 23 
in CMM and compared with AMM studies in long-axis (lx) and short-axis (sx) views.  24 
Results – The percentages of measureable cycles were 99%, 97%, and 90% for routine LV 25 
studies in CMMsx, AMMsx, and AMMlx mode. For time intervals, ≥ 93% of cycles could be 26 
measured using AMM compared to a maximum of 77% using CMM. AMMsx measurements 27 
agreed well with CMMsx measurements for LV studies; the agreement of AMMlx with CMMsx 28 
was markedly lower. The LV ejection time and the duration of electro-mechanical systole, but 29 
not the LV pre-ejection period and the index of myocardial performance, showed fair 30 
agreement between methods. Intraobserver and interobserver measurement variabilities were 31 
low for most variables. 32 
Conclusions – AMM can replace CMM for assessment of LV dimensions in horses, but is not 33 
recommended for measurement of time intervals. 34 
35 
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INTRODUCTION 36 
Echocardiography is a standard diagnostic procedure and an important part of clinical and 37 
experimental cardiac examinations in horses. Nevertheless, the echocardiographic assessment 38 
of left ventricular (LV) size and function is still a demanding challenge for veterinary 39 
cardiologists and is limited by a variety of technical, anatomical, and physiological issues.  40 
Conventional M-mode echocardiography (CMM) is widely used in current clinical practice 41 
for assessing LV size and function. Standard M-mode indices of LV size include the internal 42 
diameter of the LV cavity (LVID) and the thickness of the interventricular septum (IVS) and 43 
the LV free wall (LVPW), respectively. The LV fractional shortening (FS) and the LV 44 
internal diameter at peak systole, respectively, are the most commonly used M-mode-derived 45 
indices of LV systolic function. Other indices of LV function include systolic time intervals 46 
(pre-ejection period, PEP; ejection time, ET; and PEP/ET ratio) and the index of myocardial 47 
performance (IMP, also referred to as Tei-index).
1-6
 48 
All of the above indices are routinely measured or calculated from M-mode recordings 49 
obtained from right parasternal short-axis views or occasionally from long-axis views.
1
 The 50 
advantage of the CMM technique is the high pulse repetition frequency (200-1000 Hz), 51 
resulting in a high temporal resolution (1-5 msec) that allows accurate measurement of time 52 
intervals. The major limitation of CMM is that the cursor line can only be rotated around the 53 
apex of the imaging sector.
7
 To achieve the exact orientation, CMM studies are typically 54 
guided by reference to a simultaneously obtained two-dimensional (2D) image. However, 55 
ideal alignment is not always possible because of individual thorax conformation, interference 56 
from lung or ribs, or a limited cardiothoracic window.
8
 Furthermore, CMM does not allow 57 
tracking of valve motion during the cardiac cycle. Therefore, identification of onset and end 58 
of valve motion and measurement of time events by CMM is often difficult. 59 
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With advances in ultrasound technology such as high-frame rate 2D imaging, expanded 60 
digital cine memory, and powerful computer processing algorithms, it has become possible to 61 
develop a modified M-mode method that can overcome some of the limitations of CMM 62 
echocardiography.
8
 The so called ‘anatomical M-mode’ (AMM)a can be applied directly 63 
during the echocardiographic examination (‘live’ AMM) or it can be used as a post-64 
processing technique that creates M-mode studies from digitally stored 2D cine-loops. It 65 
allows the operator to position the M-mode cursor freely on the 2D image, independent of the 66 
sector apex. This technique also allows rendering M-mode studies from multiple orientations 67 
and updating the position of the M-mode cursor between measurements. Therefore, moving 68 
structures can be tracked during the cardiac cycle and identification of time events (i.e., valve 69 
opening and closure) is facilitated.
7,9
 With AMM it is possible to reduce the duration of the 70 
echocardiographic examination, because AMM tracings can be derived offline from standard 71 
2D recordings and can replace CMM studies that have to be conducted ‘live’. The contras of 72 
AMM are related to the relatively low recording frame rate of 2D echocardiography 73 
(approximately 50 frames per second in horses), resulting in a relatively low temporal 74 
resolution (approximately 20 ms).
7-9
 The ability to accurately and reliably measure time 75 
intervals on AMM recordings may therefore be limited. 76 
The aim of this study was to investigate the applicability and the reliability of the AMM for 77 
assessment of LV size and function in horses and to evaluate the agreement of AMM with 78 
CMM measurements. We hypothesized that indices of LV size and function by AMM can be 79 
reliably obtained and are in good agreement with CMM indices. In addition, the study aimed 80 
at establishing reference intervals for indices of LV size and function measured with AMM in 81 
healthy horses. 82 
 83 
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MATERIALS AND METHODS 84 
Study population 85 
The study population was chosen retrospectively and included horses that underwent an 86 
echocardiographic examination at The Ohio State University or at The University of Zurich 87 
between January 2005 and March 2009. Enrollment criteria were body weight > 300 kg, age > 88 
2 years, and the availability of a complete, standardized echocardiogram of good quality, with 89 
an ECG recorded simultaneously and performed by a single operator (CCS) on a digital 90 
echocardiography system
b
. Ninety-eight horses (31 females, 67 geldings) with an age of 13.1 91 
± 5.6 years (n = 97) and a body weight of 538 ± 78 kg (n = 87) fulfilled the inclusion criteria. 92 
The study population included 49 Warmblood horses, 20 Standardbreds, 13 Thoroughbreds, 6 93 
Arabians, 2 Icelandic horses, 2 Quarter horses, and 1 each of the following breeds: Haflinger, 94 
Freiberger, Paint, Cob, and Paso Fino; in 1 horse breed was not reported. All animals received 95 
adequate human care and were treated during the examination according to the ethical 96 
guidelines of the universities. 97 
Of these horses, 78 were in normal sinus rhythm (NSR) and 20 were in atrial fibrillation (AF). 98 
In the NSR group, 42 horses had a structurally and functionally normal heart. The remaining 99 
36 horses had structural or functional abnormalities as detected by echocardiography. Grading 100 
of severity of valvular regurgitation was achieved using a scoring system based on the 101 
duration of the regurgitant signal, high-velocity jet area and flow disturbance, regurgitant 102 
signal duration, and the number of imaging planes in which the high-velocity jet could be 103 
observed in the receiving chamber.
10
 The following abnormalities were diagnosed: Mild 104 
mitral regurgitation (MR) (n=6), moderate MR (n=6), severe MR (n=2), mild aortic 105 
regurgitation (AR) (n=4), moderate AR (n=3), severe AR (n=2), moderate tricuspid 106 
regurgitation (TR) (n=1), mild MR & mild AR (n=2), mild MR & moderate AR (n=2), mild 107 
MR & severe AR (n=1), moderate MR & mild AR (n=1), moderate MR & severe AR (n=1), 108 
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moderate MR & moderate TR (n=1), mild AR & mild pulmonic regurgitation (PR) (n=2), 109 
congestive heart failure with moderate MR & severe AR & moderate-to-severe TR & mild PR 110 
(n=1), and congestive heart failure due to myocarditis (n=1).  111 
In the AF group, 5 horses had a structurally normal heart as determined by echocardiography. 112 
The remaining 15 horses had one of the following diagnoses: Mild MR (n=1), mild AR (n=1), 113 
mild TR (n=2), mild PR (n=2), mild MR & moderate AR (n=1), severe MR & severe AR 114 
(n=1), moderate MR & mild PR (n=1), mild MR & mild TR (n=1), moderate MR & mild TR 115 
(n=1), mild AR & mild PR (n=1), mild AR & mild TR (n=2), moderate MR & moderate AR 116 
& moderate TR (n=1). Two of these horses had signs of pulmonary hypertension (maximum 117 
velocity of the tricuspid regurgitation jet measured by spectral Doppler exceeded 3.5 m/s) and 118 
one horse was in congestive heart failure.  119 
Echocardiography  120 
All horses underwent a complete echocardiographic examination performed by a single 121 
operator (CCS) according to a standardized protocol. During the examination, all horses were 122 
standing in a quiet room and restrained by an experienced handler. Three horses were sedated 123 
with 4 mg detomidin
c
 i.v. prior to the examination, while the remaining 95 horses were not 124 
sedated during the examination. Transthoracic 2D echocardiography and 2D-guided CMM 125 
echocardiography were performed using a high-end digital echocardiograph
b
 with a M3S or 126 
M4S transducer
d
 working at frequencies from 1.5/3.1 to 1.9/4.0 MHz (octave harmonics). The 127 
median frame rate for the 2D cine-loop recordings was 53.9 frames/s (fps), with a range of 128 
28.9 to 71.1 fps. Twenty-five echocardiograms were recorded at frame rates below 50 fps. An 129 
ECG was recorded simultaneously for timing of measurements within the cardiac cycle.  130 
All recordings were performed in standard right-parasternal imaging planes.
1
 The LV was 131 
imaged in a long-axis (four-chamber) view in 2D mode and in a short-axis view at the chordal 132 
level in 2D mode and CMM, respectively. The mitral valve (MV) was imaged in a four-133 
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chamber view in 2D mode and in a short-axis view in 2D mode and CMM, respectively. The 134 
aortic valve (AoV) was imaged in a long-axis view of the left ventricular outflow tract 135 
(LVOT) in 2D mode and in a short-axis view at the level of the valve in CMM. 136 
In each imaging plane, at least 3 representative, non-consecutive cardiac cycles were recorded 137 
in horses with NSR and at least 5 cycles were recorded in horses with AF. All images were 138 
stored either as CMM still images or as 2D cine-loops in digital raw-data format.  139 
Anatomical M-mode analyses 140 
All AMM analyses were performed offline by a single observer (PAG) using the analysis 141 
software of the echocardiography system
a
. The AMM tracings of the LV, the MV, and the 142 
AoV were generated by positioning the electronic cursor through the respective 2D cine-loop 143 
recordings. In LV short-axis view, the AMM cursor was positioned through the lumen of the 144 
LV, bisecting the interventricular septum, the LV cavity, and the LV free wall into two equal 145 
parts throughout the cardiac cycle (Figure 1). In LV long-axis view, the AMM cursor was 146 
positioned at the chordal level, parallel to the MV annulus (Figure 2). For analysis of MV 147 
motion, the AMM cursor was placed across the MV leaflets in both the long-axis recordings 148 
(parallel to the MV annulus) and in the short-axis recordings of the valve (Figures 3 and 4). 149 
For analysis of AoV motion, the AMM cursor was placed across the AoV leaflets (parallel to 150 
the AoV annulus) in the long-axis recordings of the valve (Figure 5). For correct identification 151 
of MV and AoV opening and closure, respectively, the AMM cursor was moved to follow the 152 
valve leaflets during the cardiac cycle until the opening and closure events were clearly 153 
delineated. Where these time events were not clearly visible using a single cursor position, 154 
two different cursor positions were used at end-systole (AoV closure, MV opening) and end-155 
diastole (AoV opening, MV closure). Anatomical M-mode was not applied to short-axis 156 
recordings of the AoV, because the available cine-loop recordings of the AoV and the left 157 
atrium (LA) in short axis had been optimized for measurement of the LA but not for 158 
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assessment of AoV motion, and because preceding pilot studies had shown that derived AMM 159 
tracings rarely allowed proper identification of both AoV opening and closure.  160 
 161 
Measurements 162 
All measurements were performed offline by a single observer (PAG) using the digital raw-163 
data image files. The measurements were performed on both the CMM and the AMM 164 
tracings. In horses with NSR, we attempted to analyze 3 non-consecutive, randomly chosen 165 
cardiac cycles for each imaging plane and echocardiographic modality. Cycles immediately 166 
following an incident of second degree atrio-ventricular block were excluded from analyses. 167 
In horses with AF, we attempted to analyze 5 consecutive cycles, independent of the length of 168 
the cycle. In horses, in which the available recordings did not contain a sufficient number of 169 
complete cardiac cycles for all imaging planes, all available cycles were measured. On some 170 
recordings, unambiguous identification of anatomical landmarks for measurements was not 171 
possible on all cycles. In those cases, we measured only the cycles, in which the landmarks 172 
could be clearly identified. For each variable, the number of available cycles and the number 173 
of measurable cycles were noted. The heart rate (HR) of each measured cycle was calculated 174 
based on the RR interval preceding the analyzed cycle (HR = 60,000 / RR). 175 
For LV analyses, the ‘trailing-inner-inner-leading’ edge method was used. End-diastolic 176 
measurements of LV dimensions were timed to the peak of the electrocardiographic R wave, 177 
because the onset of the R wave was not always clearly visible and the Q wave was usually 178 
absent in the lead used. End-systolic measurements of LV dimensions were made at the point 179 
of maximal excursion of the interventricular septum and the LV free wall. The following 180 
dimensions were measured on the LV tracings: The interventricular septal thickness at end-181 
diastole (IVSd) and at peak systole (IVSs), the LV internal diameter at end-diastole (LVIDd) 182 
and at peak systole (LVIDs), and the LV free wall thickness at end-diastole (LVPWd) and at 183 
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peak systole (LVPWs). The LV fractional shortening (FS, in %) was calculated as FS = 184 
(LVIDd-LVIDs)/LVIDd×100. The LV mass (in g) was calculated as LV mass = 185 
1.04×[(LVIDd+LVPWd+IVSd)
3
-LVIDd
3
] - 13.6.
11-13
 The relative LV wall thickness at end-186 
diastole (RWT) was calculated as RWT = (LVPWd+IVSd)/LVIDd. The mean LV wall 187 
thickness at end-diastole (MWT) was calculated as MWT = (LVPWd+IVSd)/2. 188 
On the MV tracings, the MV closure-to-opening interval (MVCO) was measured as the time 189 
interval from MV closure to MV opening (Figure 3 and 4). 190 
On the AoV tracings, the LV pre-ejection period (LVPEP) was measured as the time interval 191 
from the peak of the echocardiographic R wave to the opening of the AoV on the AoV 192 
tracing, and LV ejection time (LVET) was measured as the time interval from opening to 193 
closure of the AoV on the same tracing (Figure 5). The LVPEP/LVET ratio and the duration 194 
of electromechanical systole (EMS = LVPEP+LVET) were calculated. 195 
For each measured variable, the average of the realized measurements was calculated and 196 
used for further analyses. With the averaged data, the following compound indices (i.e., 197 
indices calculated from measurements made in different imaging planes and in different 198 
cardiac cycles) were calculated: The mean velocity of circumferential fiber shortening, Vcf = 199 
(LVIDd-LVIDs)/(LVIDd×LVET); the rate-corrected mean velocity of circumferential fiber 200 
shortening, Vcfc = (LVIDd-LVIDs)/(LVIDd×(LVET/√RR)); and the index of myocardial 201 
performance (Tei-Index), IMP  = (MVCO-LVET)/LVET. 202 
Measurement reliability  203 
To determine the intraobserver and interobserver measurement reliability, a subgroup of 5 204 
randomly selected horses was re-analyzed by the same observer (PAG) and by a second 205 
observer (CCS). The second analyses also included repeated generation of AMM tracings 206 
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from 2D cine-loops. Both observers were blinded to signalment, diagnosis, previously 207 
measured cycles, and previous measurements. 208 
Data analysis and statistics 209 
Graphical presentation, data analyses, and statistics were performed using commercial 210 
computer software
e,f,g
.  211 
For each variable and each echocardiographic modality (i.e., CMM, AMM), the percent ratio 212 
of measurable over available cardiac cycles was calculated.  213 
For analysis of agreement between CMM and AMM, measurements were only included if the 214 
average HR differed by less than 25%. Data points for which HR differed by > 25% between 215 
CMM and AMM were excluded from analysis, in order to reduce bias related to differences in 216 
heart rate rather than differences in echocardiographic modality. After averaging the realized 217 
measurements (i.e., 3 measurements for horses in NSR and 5 measurements for horses in AF), 218 
method agreement was assessed using Bland-Altman analyses. For each variable, mean bias 219 
and 95% limits of agreement were calculated and reported as absolute values and as percent 220 
values. The methodical details of Bland-Altman analyses have been described elsewhere.
14,15 221 
Briefly, mean bias is calculated as the mean difference between the two methods and 222 
describes the average discrepancy of measurements obtained using the two methods. The 95% 223 
limits of agreement are calculated as the mean bias plus or minus 1.96 times the standard 224 
deviation of the differences between the two methods. For any variable, the difference 225 
between measurements using the two methods will lie within the limits of agreement in 95% 226 
of the time. Hence, bias and limits of agreement are indices of comparability between two 227 
methods that have to be interpreted in relation to the magnitude of the respective variable. 228 
Therefore, summary statistics (mean ± SD) for each variable were reported for comparison. 229 
Agreement was further assessed using Lin’s concordance correlation.16 Lin’s concordance 230 
was reported as the sample concordance correlation coefficient (ρc) and its lower one-sided 231 
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95% confidence limit.
17,18
 The coefficient ranges from 0 to 1 and increases in value as a 232 
function of the nearness of the data to the line of perfect concordance and the tightness of the 233 
data about this axis. To our knowledge, there is as yet no established descriptive scale for the 234 
degree of agreement of echocardiographic variables using ρc. Accordingly, ρc was regarded as 235 
a complementary measure of agreement that was used for comparison of the different 236 
variables and echocardiographic modalities within this study rather than as an absolute 237 
measure of agreement. 238 
To establish reference intervals for the measured and calculated variables, we used the data 239 
from anamnestically and clinically healthy horses that were in normal sinus rhythm and had a 240 
structurally normal heart on echocardiographic examination. The healthy population was 241 
classified by breed into three groups: Warmbloods, Standardbreds and Thoroughbreds. For 242 
each group, reference intervals of each variable were reported with the 2.5% percentile being 243 
the lower limit and the 97.5% percentile being the upper limit of the interval. Body weight 244 
was reported as mean ± SD. 245 
Intraobserver measurement reliability and interobserver measurement reliability were 246 
quantified by the within-subject variance for repeated measurements (residual mean square) 247 
determined by 1-way analysis of variance with the horses as groups.
19
 The within-subject 248 
standard deviation (sw) was calculated as the square root of the residual mean square. 249 
Measurement variability was reported in 2 ways: (1) The within-subject coefficient of 250 
variation (CV) expressed as a percent value was calculated as CV = sw/mean ×100 in order to 251 
compare the reliability of the various variables in this study.
19
 The degree of variability was 252 
arbitrarily defined as follows: CV < 5%, very low variability; 5–15%, low variability; 16–253 
25%, moderate variability; >25%, high variability. (2) In addition to the CV, the absolute 254 
value below which the difference between 2 measurements will lie with 95% probability was 255 
estimated following the British Standards Institution (BSI) recommendations: BSI = 1.96× 256 
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√2×sw = 2.77×sw.
19
 The BSI was reported to provide a clinically applicable measure of 257 
variability, hence an absolute value that allows comparison with measured changes in 258 
echocardiographic variables on a case-by-case basis.  259 
 260 
RESULTS 261 
Table 1 summarizes the number of available cardiac cycles and the number of measurable 262 
cycles in the study population. The results show that the percentage of measureable cycles 263 
was comparable for LV studies performed in CMM in short-axis views (CMMsx) and AMM 264 
in short-axis views (AMMsx), and slightly lower for AMM in long-axis views (AMMlx). For 265 
MV and AoV time intervals, the percentage of measurable cycles was markedly higher using 266 
AMM compared to CMM. 267 
The results of the analyses of agreement are summarized in Table 2. Generally, for the LV 268 
study, AMMsx measurements agreed well with CMMsx measurements, while the agreement of 269 
AMMlx measurements was markedly lower, particularly for the septal thickness, the free wall 270 
thickness, and the derived variables (i.e., LV mass, MWT, and RWT). Among the time 271 
intervals, MVCO, LVET and EMS showed fair agreement between CMMsx and AMM 272 
measurements, while agreement of LVPEP was low. The calculated compound indices (i.e., 273 
Vcf, Vcfc, and IMP) showed markedly lower agreement than measured indices. Agreement of 274 
the IMP was poor. 275 
The reference intervals for all echocardiographic variables for clinically healthy horses are 276 
summarized in Table 3, grouped by echocardiographic modality and breed.  277 
Reliability data of all echocardiographic variables, grouped by echocardiographic modality, 278 
are summarized in Table 4. Based on the CV, intraobserver measurement variability and 279 
interobserver measurement variability were very low to low for all variables, with the 280 
exception of the IMP, showing low to moderate variability. Overall, variability was lower for 281 
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CMMsx and AMMsx compared to AMMlx. Within each echocardiographic modality, 282 
interobserver measurement variability was generally slightly higher than intraobserver 283 
measurement variability, but they were not substantially different and were in a comparable 284 
range for all variables. 285 
 286 
DISCUSSION 287 
The results of the current study indicate that AMM is readily applicable to analyze digitized 288 
2D cine-loop recordings obtained from adult horses and that – for most instances – is reliable 289 
and in good agreement with routine CMM measurements of LV size and LV function.  290 
The AMM technique offers several advantages over the CMM methodology. In clinical 291 
routine, the most useful features of AMM are the ability to generate AMM tracings offline, 292 
the free orientation of the cursor line, and the tracking capabilities.
7,9
 The fact that AMM can 293 
be applied as a post-processing feature allows reducing the time required for acquiring 294 
echocardiographic recordings by several minutes. This may be of particular interest when 295 
examining animals that need to be physically restrained during the examination. The 296 
possibility to freely orientate the cursor line permits studying any cardiac structure upon every 297 
angle of interrogation. It allows anatomically consistent placement of the cursor line, resulting 298 
in better standardization of the examination and a higher degree of accuracy and precision.
8
 299 
The tracking function allows to follow moving structures (e.g., valve leaflets) during cardiac 300 
cycle to optimize and standardize cursor placement. Accordingly, we were able to show that 301 
the AMM method facilitates the measurement of MV and AoV time intervals, with a higher 302 
percentage of measureable cycles using the AMM technique. For the LV study, the tracking 303 
feature is less critical and therefore was not used in this study. Nonetheless, the percentage of 304 
measureable cycles was only slightly lower for AMM compared to CMM.  305 
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The quality of the stored 2D cine-loops of LV short-axis planes in this study allowed 306 
generating high-quality AMMsx tracings. For routine LV measurements, the agreement of 307 
AMMsx with CMMsx and the measurement reliability were considered sufficiently high for 308 
use of AMM in clinical applications.  309 
For LV measurements in AMMlx, the percentage of measurable cycles, the agreement with 310 
CMMsx measurements, and the measurement reliability were lower than observed in AMMsx. 311 
This can be explained by a variety of methodological and technical issues. In some 312 
recordings, generation of AMMlx tracings of the LV was hampered by inadequate image 313 
quality of the stored 2D cine-loops, in which the LV free wall could not be clearly identified. 314 
Another difficulty in AMMlx tracings was the covering of the IVS by the tricuspid valve 315 
leaflet, impairing the ability to clearly identify the right-ventricular surface of the IVS. 316 
Because no measurements were taken from cycles where the anatomical landmarks (i.e., the 317 
endocardial and epicardial linings) could not be clearly identified, this resulted in a slightly 318 
lower percentage of measurable cycles in AMMlx compared to AMMsx or CMMsx recordings.  319 
Unlike AMMsx tracings, AMMlx tracings are obtained in an imaging plane that differs from 320 
the plane used for CMMsx recordings. Therefore, although the same anatomical structures are 321 
studied in AMMsx and AMMlx, placement of the cursor line and the resulting measurements 322 
will inevitably be different. In both short-axis and long-axis imaging planes, translational 323 
motion of the heart causes changes of the position of the cursor line relative to the LV cavity, 324 
adds to measurement error, and decreases method agreement. Consistent placement of the 325 
AMM cursor in a LV long-axis view, at the chordal level, parallel to the mitral valve annulus, 326 
and without excessive interaction of the mitral valve leaflets, is hindered by the base-to-apex 327 
shortening effect of the LV during the cardiac cycle. Furthermore, translational motion of the 328 
heart can also result in changing orientation of the imaging plane during the cardiac cycle, so 329 
that it does not always cross the LV at its maximum dimension. Obviously, translational 330 
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motion and base-to-apex shortening effect are also present when recording 2D or CMM 331 
images in short-axis planes. However, they are less obvious to the observer and may affect 332 
measurements to a lesser degree, as long as the cursor line crosses the LV at its widest 333 
dimension throughout the cardiac cycle. The detailed investigation of the influence of 334 
translational motion and base-to-apex LV shortening on the accuracy of AMM measurements 335 
was beyond the scope of this study. 336 
The results indicate that AMM facilitates measurement of systolic time intervals by virtue of 337 
its tracking function. Tracking allows following the spatial position of the moving valves 338 
throughout the cardiac cycle, making it easier to identify the valve opening and the valve 339 
closure on the AMM tracing. Conversely, CMM does not allow tracking of moving structures 340 
and often does not depict time events clear enough to allow accurate and reliable 341 
measurement of time intervals. In this study, MVCO, LVET, and EMS by AMM could be 342 
measured reliably in over 90% of the cycles and showed fair agreement with CMMsx 343 
measurements. The reliability and agreement with CMM of LVPEP and LVPEP/LVET by 344 
AMM were markedly lower, most likely because of the relatively short duration of the 345 
LVPEP, rendering it more susceptible to measurement errors and influence of low temporal 346 
resolution (see below). Therefore, the clinical use of LVPEP and LVPEP/LVET by AMM 347 
analysis of aortic valve motion is not recommended in horses. 348 
Measurement of MVCO is primarily useful for calculation of the IMP, which is an index of 349 
combined systolic and diastolic myocardial performance. However, mitral valve motion is not 350 
only determined by LV myocardial function, but is also influenced by LV end-diastolic 351 
pressure, aortic insufficiency, and duration of the PQ interval, resulting in premature or 352 
delayed mitral valve closure.
20
 This may result in difficulties measuring the MVCO and may 353 
indirectly impair the accuracy of the IMP to represent myocardial performance. Another 354 
problem when calculating the IMP using M-mode measurements of MVCO and LVET is the 355 
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fact that time intervals are measured sequentially in different imaging planes and in different 356 
cardiac cycles. Consequently, the accuracy of the results may be compromised by fluctuations 357 
in HR.
5
 To minimize the effect of HR in this study, the difference in HR between AMM and 358 
CMM measurements had to be less than 25%. Nonetheless, the IMP by AMM showed 359 
inferior agreement with CMM compared to other measurements and was characterized by 360 
only moderate reliability. Therefore, we suggest that derivation of the IMP from CMM or 361 
AMM tracings should not be recommended in horses.  362 
Measurement variability is relevant to the study of method agreement because the 363 
measurement errors inherent to the two methods being compared limit the degree of 364 
agreement which is possible.
14
 If one or both methods have high measurement variability, the 365 
agreement between the two methods will be poor as well. Hence, comparison of the 95% 366 
limits of agreement obtained from Bland-Altman analyses with the BSI value obtained from 367 
variability analyses provides additional information on the influences of measurement error 368 
on method agreement. Generally, the higher the BSI value is, the larger the influence of 369 
measurement error on method agreement will be. Overall, for LV measurements, variability 370 
was low and method agreement was high. Conversely, the measurement variability was 371 
higher, and the method agreement lower, for LVPEP, LEPEP/LVET, and IMP. For most 372 
instances, the interobserver variability was only slightly higher than the intraobserver 373 
variability, indicating that the AMM method is relatively robust to observer-related 374 
measurement errors. 375 
The retrospective design of the study needs to be listed as one of its limitations. However, the 376 
fact that in both hospital locations one single operator performed all echocardiographic 377 
recordings following a standardized protocol and using the same type of digital ultrasound 378 
equipment certainly minimized the error introduced due to different recording techniques. 379 
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AMM studies are derived from 2D cine-loops and therefore are affected by the limitations of 380 
2D echocardiography, namely lower resolution and frame rates. The CMM studies benefit 381 
from high pulse repetition frequency available for interrogation. The pulse repetition 382 
frequency provides a high degree of temporal and axial resolution that is ideal for study of 383 
mobile cardiac structures. In this study, 25 echocardiograms were recorded at frame rates 384 
below 50 fps, resulting in low temporal resolution (i.e., > 20 ms). This may particularly have 385 
influenced agreement and reliability of the short-lasting LVPEP and the related 386 
LVPEP/LVET ratio. However, the majority of studies were recorded at frame rates above 50 387 
fps. Furthermore, 3 to 5 measurements were averaged for each cycle, likely removing some of 388 
the effects of measurement error due to low temporal resolution. Nonetheless, as discussed 389 
above, the results of this study suggest that AMM may not be suitable for measurement of 390 
short-lasting time events in horses. 391 
Another limitation concerns the reference intervals reported in this study. Reference intervals 392 
were reported for all variables, even for those where the number of available horses was very 393 
low. However, reference intervals should ideally be determined on populations larger than 50 394 
to 100 individuals.
21
 Therefore, the intervals reported here must be interpreted with caution 395 
and should be regarded as preliminary. 396 
 397 
CONCLUSIONS 398 
In conclusion, the present study shows that AMM is applicable for assessment of LV size and 399 
function in horses. The results suggest that AMMsx can replace CMMsx for routine assessment 400 
of LV size and function, with generally high method agreement and adequate measurement 401 
reliability. However, it needs to be recognized that AMM measurements largely depend on 402 
the quality of the 2D cine-loop recordings that are used to generate the AMM tracings. 403 
Therefore, the availability of high-end digital echocardiography equipment is an important 404 
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prerequisite to produce high-quality AMM tracings with adequately high frame rates. But 405 
even with appropriate equipment, accurate measurement of short-lasting time intervals is 406 
limited. Furthermore, M-mode measurements are limited to a single dimension, disregarding 407 
the fact that the heart is a complex three-dimensional structure. Recent human imaging 408 
guidelines emphasize the advantages of area-based and volume-based indices for assessment 409 
of chamber dilation and dysfunction, because linear measurements may be somewhat 410 
insensitive, particularly in the presence of non-uniform chamber enlargement, alterations in 411 
chamber geometry, and presence of regional wall motion abnormalities.
22
 Therefore, one can 412 
argue that echocardiographic measurements should be made directly within the 2D recordings 413 
instead of using the derived AMM tracings. This would offer the advantage that two-414 
dimensional area measurements and three-dimensional volume estimates could be obtained. 415 
In fact, the use of M-mode measurements may be regarded somewhat antiquated and is 416 
largely based on traditional conventions that were agreed on in times when the quality of 2D 417 
echocardiograms was still hampered by very low resolution and frame rates. However, M-418 
mode measurements are still widely used for assessment of LV size and function in horses 419 
and may actually be superior to 2D cine-loop recordings for subjective visual assessment of 420 
LV wall motion patterns and LV systolic function. This study was not aimed at comparing the 421 
use of linear M-mode measurements with linear dimensions, area measurements, or volume 422 
estimates obtained from 2D echocardiograms. Therefore, further studies will be needed to 423 
show if M-mode measurements of LV size and function should still be considered state-of-424 
the-art in the age of high-quality digital echocardiography. 425 
 426 
427 
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FOOTNOTES 428 
a
EchoPAC Software v6.1.2, GE Medical Systems, Milwaukee, WI. 429 
b
GE Vivid 7 ultrasound system, GE Medical Systems, Milwaukee, WI. 430 
c
Detomidine (Domosedan®), Pfizer AG, Berlin, Germany. 431 
d
M3S and M4S phased array transducer, GE Medical Systems, Milwaukee, WI. 432 
e
Microsoft Office Excel 2008, Microsoft Corporation, Redmond, WA. 433 
f
GraphPad Prism v5.02 for Windows, GraphPad Software, San Diego, CA. 434 
g
SigmaStat v3.5, SPSS Inc, Chicago, IL.435 
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TABLES AND FIGURES 436 
Table 1: Ratio of measurable cardiac cycles over available cardiac cycles for conventional M-437 
mode applied to short-axis imaging planes (CMMsx) and anatomical M-mode applied to short-438 
axis (AMMsx) and long-axis (AMMlx) imaging planes. 439 
Table 2: Analysis of agreement between CMM and AMM measurements. 440 
Table 3: Reference intervals for CMM and AMM measurements in clinically healthy horses 441 
in normal sinus rhythm, reported as the interval between the 2.5% and the 97.5% percentile. 442 
Table 4: Reliability of echocardiographic variables of LV size and function measured by 443 
CMM and AMM. 444 
 445 
Figure 1: Anatomical M-mode image of the left ventricle (LV), reconstructed from a digitally 446 
stored 2D cineloop recording obtained from a right parasternal short-axis view at the chordal 447 
level. The AMM cursor line (green) is positioned through the lumen of the LV, bisecting the 448 
interventricular septum (IVS), the LV cavity, and the LV free wall (LVPW) into two equal 449 
parts throughout the cardiac cycle. An ECG is superimposed for timing. 450 
Figure 2: Anatomical M-mode image of the left ventricle (LV), reconstructed from a digitally 451 
stored 2D cineloop recording obtained from a right parasternal long-axis view. Notice that the 452 
AMM cursor line (green) is positioned at the chordal level, parallel to the MV annulus and 453 
does not originate from the top of the 2D imaging sector. A chordal trace is visible within the 454 
LV lumen (arrowheads). The tip of the septal mitral valve leaflet appears in the LV lumen as 455 
it crosses the cursor line during early diastole (arrows). IVS, interventricular septum; LVPW, 456 
LV free wall. 457 
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Figure 3: Anatomical M-mode images of mitral valve motion, reconstructed from a digitally 458 
stored 2D cineloop recording obtained from a right parasternal long-axis view. The AMM 459 
cursor line (green) is placed across the MV leaflets. Depending on the position of the cursor 460 
line, the time of mitral valve closure (Figure 3A, MVC) or mitral valve opening (Figure 3B, 461 
MVO) can be identified. The ability to track mitral valve motion by AMM greatly facilitates 462 
measuring the mitral valve closure-to-opening time compared to conventional M-mode 463 
imaging. 464 
Figure 4: Anatomical M-mode image of mitral valve motion, reconstructed from a digitally 465 
stored 2D cineloop recording obtained from a right parasternal short-axis view at the level of 466 
the mitral valve. The AMM cursor line (green) is placed across the MV leaflets. Notice that in 467 
this example, both the time of mitral valve closure (MVC) and the time of mitral valve 468 
opening (MVO) can be identified on the same AMM tracing. 469 
Figure 5: Anatomical M-mode images of aortic valve motion, reconstructed from a digitally 470 
stored 2D cineloop recording obtained from a right parasternal long-axis view of the left 471 
ventricular outflow tract. The AMM cursor line is placed across the AoV leaflets, parallel to 472 
the AoV annulus. Depending on the position of the cursor line, the time of aortic valve 473 
opening (Figure 5A, AVO) or aortic valve closure (Figure 5B, AVC) can be identified. The 474 
ability to track aortic valve motion by AMM greatly facilitates measuring the systolic time 475 
intervals compared to CMM imaging. 476 
 477 
478 
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Table 1: Ratio of measurable cardiac cycles over available cardiac cycles for conventional M-mode 
applied to short-axis imaging planes (CMMsx) and anatomical M-mode applied to short-axis (AMMsx) 
and long-axis (AMMlx) imaging planes.  
 LV study MVCO LVPEP, LVET 
CMMsx 309/312 
(99 %) 
237/307 
(77 %) 
160/306 
(52 %) 
AMMsx 255/263 
(97 %) 
224/229 
(98 %) 
– 
AMMlx 264/295 
(90 %) 
285/299 
(95 %) 
268/287 
(93 %) 
 
LV study: Measurements of left ventricular dimensions (see Table 2). MVCO: Mitral valve closure-to-
opening interval. LVPEP: Left ventricular pre-ejection period. LVET: Left ventricular ejection time.
  
Table 1
Table 2: Analysis of agreement between CMM and AMM measurements.  
 
 
LV: Left ventricle. MV: Mitral valve. AoV: Aortic valve.  
  CMMsx AMMsx AMMlx 
    Bland-Altman Analysis 
Lin`s Concordance 
Coefficient 
 Bland-Altman Analysis 
Lin`s Concordance 
Coefficient 
 Variable Mean ± SD Mean ± SD 
Bias 
(absolute) 
95% LA 
(absolute) 
Bias  
(%) 
95% LA 
(%) 
ρc 
Lower 95% 
CL 
Mean ± SD 
Bias 
(absolute) 
95% LA 
(absolute) 
Bias 
(%) 
95% LA 
(%) 
ρc 
Lower 95% 
CL 
L
V
 
HR (/min) 41 ± 10 41 ± 11 - 0.1 - 6.4 to 6.1 - 0.3 - 14.9 to 14.3 0.96 0.94 42 ± 10 0.7 - 10.0 to 11.5 1.7 - 23.2 to 26.7 0.85 0.80 
IVSd (cm) 3.1 ± 0.4 3.1 ± 0.4 - 0.04 - 0.54 to 0.45 - 1.3 - 17.3 to 14.6 0.81 0.74 2.4 ± 0.4 - 0.72 - 1.62 to 0.19 - 26.1 - 58.5 to 6.4 0.14 0.06 
LVIDd (cm) 12.0 ± 1.5 12.0 ± 1.6 0.03 - 0.94 to 0.99 0.3 - 7.9 to 8.4  0.95 0.93 12.1 ± 1.4 0.06 - 1.43 to 1.56 0.7 - 11.9 to 13.3 0.87 0.82 
LVPWd (cm) 2.5 ± 0.4 2.4 ± 0.4 - 0.05 - 0.68 to 0.58 - 2.3 - 28.3 to 23.6 0.71 0.62 2.3 ± 0.4 - 0.12 - 0.92 to 0.68 - 4.4 - 37.6 to 27.6 0.54 0.41 
IVSs (cm) 4.5 ± 0.5 4.6 ± 0.5 0.03 - 0.81 to 0.86 0.6 - 18.4 to 19.7 0.69 0.59 3.7 ± 0.8 - 0.81 - 2.34 to 0.71 - 20.8 - 55.5 to 13.9 0.20 0.10 
LVIDs (cm) 7.3 ± 1.1 7.3 ± 1.1 0.01 - 1.20 to 1.22 0.2 - 18.0 to 18.4 0.84 0.79 7.4 ± 1.3 0.04 - 1.78 to 1.86 0.1 - 25.0 to 25.2 0.72 0.62 
LVPWs (cm) 4.2 ± 0.6 4.2 ± 0.6 - 0.01 - 0.66 to 0.63 - 0.6 - 16.3 to 15.1 0.83 0.76 4.2 ± 0.6 - 0.18 - 1.26 to 0.91 - 4.8 - 35.5 to 26.0 0.57 0.45 
LV FS (%) 39 ± 6 39 ± 6 0.0 - 8.4 to 8.4 - 0.1 - 21.1 to 20.9 0.74 0.65 39 ± 6 0.3 - 13.7 to 14.4 0.9 - 36.0 to 37.9 0.36 0.19 
LV mass (g) 3938 ± 930 3857 ± 967 - 68.9 - 1033.0 to 895.1 - 2.0 - 27.8 to 23.7 0.86 0.81 3152 ± 790 -755.9 - 1805.0 to 293.0 - 21.4 - 49.5 to 6.9 0.59 0.50 
MWT (cm)  2.8 ± 0.3 2.8 ± 0.4 - 0.05 - 0.46 to 0.37 - 1.8 - 17.0 to 13.5 0.81 0.75 2.4 ± 0.3 - 0.42 - 1.01 to 0.17 - 16.3 - 39.0 to 6.4 0.36 0.26 
RWT  0.48 ± 0.10 0.47 ± 0.10 - 0.010 - 0.086 to 0.067 - 2.1 - 18.8 to 14.7 0.93 0.90 0.42 ± 0.10 - 0.060 - 0.221 to 0.102 - 13.7 - 47.8 to 20.6 0.56 0.45 
Vcf (circ/s) 0.85 ± 0.19 0.91 ± 0.18 0.052 - 0.188 to 0.293 6.2 - 19.7 to 32.1 0.75 0.64 0.92 ± 0.22 0.062 - 0.350 to 0.474 6.5 - 36.5 to 49.4 0.51 0.35 
Vcfc (circ/s) 1.02 ± 0.17 1.11 ± 0.19 0.054 - 0.235 to 0.342 5.3 - 20.6 to 31.1 0.55 0.37 1.12 ± 0.20 0.067 - 0.383 to 0.517 6.2 - 35.5 to 47.9 0.28 0.07 
M
V
 
HR (/min) 42 ± 12 42 ± 13 - 0.4 - 8.2 to 7.5 - 0.5 - 18.0 to 17.1 0.92 0.89 43 ± 12 1.3 - 6.4 to 9.05 3.0 - 14.2 to 20.1 0.93 0.91 
MVCO (ms) 572 ± 78 595 ± 82 21.2 - 53.5 to 95.9 3.6 - 8.7 to 15.9 0.83 0.77 586 ± 81 18.7 - 63.6 to 101.1 3.2 - 10.9 to 17.4 0.81 0.74 
IMP 0.28 ± 0.17 0.36 ± 0.12 0.095 - 0.134 to 0.323 36.2 - 43.5 to 115.8 0.47 0.29 0.35 ± 0.12 0.090 - 0.155 to 0.336 39.4 - 59.8 to 138.7 0.53 0.37 
A
o
V
 
HR (/min) 43 ± 12 
 
42 ± 11 - 0.1 - 9.1 to 8.9 0.2 - 19.0 to 19.3 0.93 0.90 
LVPEP (ms) 74 ± 32 81 ± 28 12.7 - 22.0 to 47.3 19.0 - 27.6 to 65.6 0.77 0.68 
LVET (ms) 460 ± 61 437 ± 51 - 26.0 - 92.2 to 40.1 - 5.7 - 20.3 to 8.9 0.76 0.67 
LVPEP/LVET 0.17 ± 0.09 0.19 ± 0.09 0.039 - 0.056 to 0.134 24.6 - 27.9 to 77.1 0.80 0.72 
EMS (ms) 534 ± 55 517 ± 52 - 13.3 - 75.1 to 48.4 - 2.4 - 14.3 to 9.5 0.81 0.73 
Table 2
CMMsx: Conventional M-mode short-axis. AMMsx: Anatomical M-mode short-axis. AMMlx: Anatomical M-mode long-axis.  
SD: Standard deviation. LA: Limits of agreement. ρc: Concordance correlation coefficient. CL: Confidence limit. 
HR: Heart Rate. IVSd: Interventricular septal thickness at end-diastole. LVIDd: Left ventricular internal diameter at end-diastole. LVPWd: Left ventricular free 
wall thickness at end-diastole. IVSs: Interventricular septal thickness at peak systole. LVIDs: Left ventricular internal diameter at peak systole. LVPWs: Left 
ventricular free wall thickness at peak systole. LV FS: Left ventricular fractional shortening. LV mass: Left ventricular mass. MWT: Mean left ventricular wall 
thickness at end-diastole. RWT: Relative left ventricular wall thickness at end-diastole. Vcf: Mean velocity of circumferential fiber shortening. Vcfc: Rate-
corrected mean velocity of circumferential fiber shortening. MVCO: Mitral valve closure-to-opening interval. IMP: Index of myocardial performance. LVPEP: 
Left ventricular pre-ejection period. LVET: Left ventricular ejection time. EMS: Duration of electromechanical systole.  
 
Table 3: Reference intervals for CMM and AMM measurements in clinically healthy horses in normal sinus rhythm, reported as the interval between the 
2.5% and the 97.5% percentile.  
 
 CMMsx AMMsx AMMlx 
Breed Warmbloods Standardbreds Thoroughbreds Warmbloods Standardbreds Thoroughbreds Warmbloods Standardbreds Thoroughbreds 
BWT (kg) 550 ± 59 539 ± 31 548 ± 59 550 ± 59 539 ± 31 548 ± 59 550 ± 59 539 ± 31 548 ± 59 
L
V
 
HR (/min) 
32 – 66 
(n = 13) 
28 – 49 
(n = 15) 
29 – 55 
(n = 7) 
30 – 67 
(n = 13) 
32 – 48 
(n = 9) 
30 – 50 
(n = 4) 
34 – 68 
(n = 11) 
29 – 51 
(n = 9) 
31 – 47 
(n = 5) 
IVSd (cm) 
2.7 – 3.8 
(n = 13) 
2.5 – 3.8 
(n = 15) 
3.0 – 3.7 
(n = 7) 
2.7 – 3.5 
(n = 13) 
2.9 – 3.5 
(n = 9) 
2.9 – 3.8 
(n = 4) 
2.1 – 3.0 
(n = 11) 
1.8 – 3.0 
(n = 9) 
2.0 – 3.2 
(n = 5) 
LVIDd (cm) 
9.9 – 12.9 
(n = 13) 
10.2 – 13.2 
(n = 15) 
10.9 – 13.6 
(n = 7) 
10.1 – 13.3 
(n = 13) 
10.0 – 13.7 
(n = 9) 
10.9 – 12.9 
(n = 4) 
10.7 – 12.6 
(n = 11) 
11.0 – 14.3 
(n = 9) 
11.6 – 12.6 
(n = 5) 
LVPWd (cm) 
1.9 – 2.9 
(n = 13) 
1.7 – 3.1 
(n = 15) 
2.2 – 2.7 
(n = 7) 
1.8 – 3.2 
(n = 13) 
1.7 – 2.9 
(n = 9) 
2.3 – 2.9 
(n = 4) 
1.9 – 2.5 
(n = 11) 
1.8 – 3.6 
(n = 9) 
2.0 – 2.6 
(n = 5) 
IVSs (cm) 
4.5 – 5.2 
(n = 13) 
3.8 – 5.5 
(n = 15) 
4 – 5.2 
(n = 7) 
4.1 – 5.4 
(n = 13) 
4.2 – 5.6 
(n = 9) 
4.1 – 5.2 
(n = 4) 
3.7 – 4.4 
(n = 11) 
2.8 – 4.5 
(n = 9) 
3.4 – 4.4 
(n = 5) 
LVIDs (cm) 
5.5 – 8.3 
(n = 13) 
5.3 – 8.9 
(n = 15) 
6.6 – 8.7 
(n = 7) 
5.9 – 8.8 
(n = 13) 
5.0 – 9.0 
(n = 9) 
6.7 – 9.4 
(n = 4) 
5.7 – 8.6 
(n = 11) 
5.6 – 8.8 
(n = 9) 
6.4 – 8.3 
(n = 5) 
LVPWs (cm) 
3.5 – 4.9 
(n = 13) 
2.7 – 4.3 
(n = 15) 
3.9 – 4.7 
(n = 7) 
3.0 – 5.1 
(n = 13) 
2.7 – 4.6 
(n = 9) 
4 – 4.6 
(n = 4) 
3.2 – 4.3 
(n = 11) 
3.2 – 4.8 
(n = 9) 
4.0 – 4.7 
(n = 5) 
LV FS (%) 
33 – 46 
(n = 13) 
31 – 49 
(n = 15) 
32 – 42 
(n = 7) 
32 – 49 
(n = 13) 
33 – 50 
(n = 9) 
32 – 42 
(n = 4) 
30 – 52 
(n = 11) 
25 – 51 
(n = 9) 
34 – 45 
(n = 5) 
LV mass (g) 
2482 – 4649 
(n = 13) 
2100 – 5477 
(n = 15) 
3262 – 4733 
(n = 7) 
2598 – 5550 
(n = 13) 
2410 – 5040 
(n = 9) 
2197 – 5876 
(n = 4) 
2253 – 3725 
(n = 11) 
1890 – 4368 
(n = 9) 
2594 –3897 
(n = 5) 
MWT (cm) 
2.4 – 3.2 
(n = 13) 
2.2 – 3.5 
(n = 15) 
2.7 – 3.2 
(n = 7) 
2.4 – 3.2 
(n = 13) 
2.4 – 3.2 
(n = 9) 
2.6 – 3.4 
(n = 4) 
2.0 – 2.6 
(n = 11) 
1.9 – 3.2 
(n = 9) 
2.1 – 2.7 
(n = 5) 
RWT 
0.41 – 0.63 
(n = 13) 
0.39 – 0.56 
(n = 15) 
0.40 – 0.56 
(n = 7) 
0.38 – 0.61 
(n = 13) 
0.38 – 0.57 
(n = 9) 
0.41 – 0.62 
(n = 4) 
0.33 – 0.47 
(n = 11) 
0.32 – 0.54 
(n = 9) 
0.36 – 0.43 
(n = 5) 
Vcf (circ/s) 
0.66 – 1.03 
(n = 8) 
0.57 – 0.90 
(n = 5) 
0.64 – 0.86 
(n = 4) 
0.70 – 1.03 
(n = 12) 
0.73 – 1.07 
(n = 8) 
0.79 – 0.83 
(n = 2) 
0.67 – 1.13 
(n = 11) 
0.62 – 1.18 
(n = 8) 
0.78 – 1.04 
(n = 4) 
Table 3
  
 
 
 
 
 
 
 
 
 
BWT: Body weight (reported as mean ± SD). For remainder of the key see Table 2. 
Vcfc (circ/s) 
0.83 – 1.19 
(n = 8) 
0.75 – 1.04 
(n = 5) 
0.84 – 1.14 
(n = 4) 
0.88 – 1.31 
(n = 12) 
0.92 – 1.30 
(n = 8) 
0.98 – 1.03 
(n = 2) 
0.88 – 1.26 
(n = 11) 
0.68 – 1.40 
(n = 8) 
0.96 – 1.33 
(n = 4) 
M
V
 
HR (/min) 
36 – 70 
(n = 12) 
28 – 52 
(n = 11) 
30 – 73 
(n = 6) 
35 – 67 
(n = 12) 
32 – 47 
(n = 5) 
33 – 37 
(n = 3) 
34 – 67 
(n = 12) 
29 – 51 
(n = 10) 
32 – 46 
(n = 5) 
MVCO (ms) 
441 – 673 
(n = 12) 
516 – 671 
(n = 11) 
361 – 769 
(n = 6) 
450 – 706 
(n = 12) 
543 – 684 
(n = 5) 
547 – 599 
(n = 3) 
457 – 736 
(n = 12) 
525 – 692 
(n = 10) 
608 – 643 
(n = 5) 
IMP 
0.13 – 0.40 
(n = 6) 
0.01 – 0.49 
(n = 4) 
0.06 – 0.43 
(n = 3) 
0.18 – 0.49 
(n = 11) 
0.19 – 0.62 
(n = 5) 
0.24 – 0.37 
(n = 2) 
0.20 – 0.53 
(n = 12) 
0.15 – 0.46 
(n = 7) 
0.30 – 0.48 
(n = 4) 
A
o
V
 
HR (/min) 
30 – 68 
(n = 8) 
29 – 46 
(n = 4) 
34 – 44 
(n = 4) 
 
34 – 64 
(n = 13) 
29 – 50 
(n = 12) 
32 – 58 
(n = 6) 
LVPEP (ms) 
37 – 61 
(n = 8) 
50 – 110 
(n = 4) 
52 – 104 
(n = 4) 
47 – 94 
(n = 13) 
52 – 99 
(n = 11) 
52 – 86 
(n = 6) 
LVET (ms) 
388 – 532 
(n = 8) 
386 – 547 
(n = 4) 
458 – 538 
(n = 4) 
381 – 488 
(n = 13) 
397 – 483 
(n = 11) 
370 – 488 
(n = 6) 
LVPEP/LVET 
0.07 – 0.13 
(n = 8) 
0.10 – 0.29 
(n = 4) 
0.10 – 0.23 
(n = 4) 
0.11 – 0.20 
(n = 13) 
0.12 – 0.21 
(n = 11) 
0.14 – 0.18 
(n = 6) 
EMS (ms) 
440 – 588 
(n = 8) 
497 – 614 
(n = 4) 
562 – 600 
(n = 4) 
429 – 573 
(n = 13) 
477 – 582 
(n = 11) 
421 – 575 
(n = 6) 
Table 4: Reliability of echocardiographic variables of LV size and function measured by CMM and AMM. 
 
CV%: Coefficient of variation (%). BSI: Absolute value below which the difference between two measurements will lie with 95% probability (following the 
British Standards Institution). For remainder of the key see Table 2. 
 
 
 CMMsx AMMsx AMMlx 
 Intraobserver Interobserver Intraobserver Interobserver Intraobserver Interobserver 
Variable CV% BSI CV% BSI CV% BSI CV% BSI CV% BSI CV% BSI 
L
V
 
HR (/min) 1.3 1.3 0.8 0.8 1.9 1.9 1.9 1.9 0.8 0.8 2.9 2.9 
IVSd (cm) 1.9 0.18 2.3 0.22 1.0 0.10 1.6 0.15 9.3 0.70 14.5 1.16 
LVIDd (cm) 1.4 0.46 1.6 0.53 1.6 0.54 2.2 0.75 2.8 0.93 2.2 0.74 
LVPWd (cm) 3.1 0.24 7.6 0.59 3.1 0.23 6.1 0.46 8.4 0.63 4.9 0.35 
IVSs (cm) 2.1 0.29 5.3 0.73 3.9 0.53 4.8 0.64 6.4 0.68 4.0 0.43 
LVIDs (cm) 2.1 0.42 4.7 0.96 1.8 0.36 4.0 0.80 3.1 0.64 4.3 0.92 
LVPWs (cm) 2.0 0.26 1.6 0.21 2.6 0.35 1.2 0.16 5.9 0.75 3.7 0.47 
LV FS (%) 3.6 4.1 5.7 6.2 1.1 1.3 5.1 5.7 4.6 4.9 9.3 9.5 
LV mass (g) 2.5 418.1 4.5 778.7 2.5 406.0 4.4 736.1 6.5 919.1 9.0 1299.8 
MWT (cm) 1.3 0.11 4.0 0.34 1.1 0.09 2.8 0.23 6.4 0.49 7.7 0.59 
RWT 1.9 0.028 5.7 0.083 2.0 0.028 4.8 0.069 9.7 0.125 9.0 0.115 
Vcf (circ/s) 2.3 
 
0.055  5.3  0.122  3.6  0.094  3.3 0.081 3.0  0.076  8.6 0.200 
Vcfc (circ/s) 2.4 
 
0.074  5.5  0.162  3.7  0.123  3.1 0.099 3.1  0.100  7.8 0.236 
M
V
 HR (/min) 2.1 2.1 2.8 2.8 1.2 1.2 1.1 1.1 1.9 1.9 3.2 3.2 
MVCO (ms) 1.3 22.5 2.5 41.2 3.7 62.8 4.2 70.4 3.8 65.4 6.4 107 
IMP 11.3  0.079 16.9  0.124  12.6  0.135  16.7 0.168 22.6  0.243  24.7 0.249 
A
o
V
 
HR (/min) 0.9 
 
0.9  3.6  3.8  
 
0.3  0.3  1.6 1.6 
LVPEP (ms) 7.9 
 
14.9  11.0  18.7  10.8  24.1  11.7 25.5 
LVET (ms) 2.6 
 
35.2  3.6  47.1  3.0  36.4  2.9 35.4 
LVPEP/LVET 6.5  0.026  12.6  0.046  13.0  0.066  14.3 0.071 
EMS (ms) 3.0  45.5  3.2  46.8  1.9  20.1  1.5 22.3 
Table 4
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